Key statistics
As of last trade, Cytek Biosciences Inc (8EQ:FRA) traded at 3.56, 69.52% above the 52 week low of 2.10 set on May 23, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 3.56 |
|---|---|
| High | 3.56 |
| Low | 3.56 |
| Bid | 3.58 |
| Offer | 3.70 |
| Previous close | 3.68 |
| Average volume | 2.88k |
|---|---|
| Shares outstanding | 127.86m |
| Free float | 116.00m |
| P/E (TTM) | -- |
| Market cap | 551.10m USD |
| EPS (TTM) | -0.1011 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 08:55 GMT.
More ▼
Announcements
- TIME Recognizes Cytek® Biosciences as One of America’s Growth Leaders of 2026
- Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year
- Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry
- Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth
- Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA
- Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
- Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025
- Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System
More ▼
